Cargando…

Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination

Detalles Bibliográficos
Autores principales:	Asgarzdeh, Ali, Habibzadeh, Shahram, Asghariazar, Vahid, Safarzadeh, Elham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Masson SAS. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527185/ https://www.ncbi.nlm.nih.gov/pubmed/36195274 http://dx.doi.org/10.1016/j.clinre.2022.102028

Ejemplares similares

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

Drug induced hepatitis and SARS-CoV-2 vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality
por: Rocco, Alba, et al.
Publicado: (2021)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Another case of autoimmune hepatitis after SARS-CoV-2 vaccination – still casualty?
por: Londoño, Maria-Carlota, et al.
Publicado: (2021)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

Immunophenotyping of SARS-CoV-2 and vaccine design
por: Cimolai, Nevio
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Co-Occurrence of Multiple Endocrine Abnormalities Induced by the DIHS/DRESS
por: Deng, Mingqun, et al.
Publicado: (2019)

Commentary: SARS-CoV-2 vaccines and cancer patients
por: Corti, C., et al.
Publicado: (2021)

Impact of SARS-CoV-2 vaccines on the nervous system
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022)

Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccinations can trigger polyradiculitis
por: Finsterer, Josef, et al.
Publicado: (2022)

Subacute thyroiditis and different SARS-CoV-2 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Let’s leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world
por: Crespo, Javier, et al.
Publicado: (2021)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2023)

Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab
por: Khayat-Khoei, Mahsa, et al.
Publicado: (2021)

Vitamin D deficiency and inactivated SARS-CoV-2 vaccines
por: Wu, Chia-Chao, et al.
Publicado: (2021)

Deaths associated with newly launched SARS-CoV-2 vaccination
por: Mungmunpuntipamtip, Rujittika, et al.
Publicado: (2021)

Lack of vaccination in ventilated patients for SARS-CoV-2 in France
por: Joannes-Boyau, Olivier, et al.
Publicado: (2022)

Acute interstitial nephritis following SARS-CoV-2 vaccination
por: Wu, Henry H L, et al.
Publicado: (2021)

Glomerular endothelial injury following vaccination for SARS-CoV-2
por: Tanemoto, Masayuki, et al.
Publicado: (2021)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

Screening for SARS-CoV-2 antibodies to save vaccine doses
por: Fenollar, Florence, et al.
Publicado: (2022)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

Post-SARS-CoV-2 vaccination thrombosis is frequent and ubiquitous
por: Finsterer, Josef
Publicado: (2022)

Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2023)

There is an urgent need for safer anti-SARS-CoV-2 vaccines
por: Finsterer, Josef
Publicado: (2022)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh
por: Islam, Md. Samiul, et al.
Publicado: (2021)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
por: Dutta, Noton K., et al.
Publicado: (2020)

Correspondence on “Lack of vaccination in ventilated patients for SARS-CoV-2 in France”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Herd immunity threshold for SARS-CoV-2 and vaccination effectiveness in Brazil
por: Siqueira, Priscila C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_78dmh3qsks2nrvh1fkoivpbusm